Faculty from the University of Notre Dame will present their research at the Walther Cancer Foundation Symposium Feb. 2-3 (Friday-Saturday). The two-day event is hosted by the Harper Cancer Research Institute (HCRI) and will take place at the Eck Visitors Center.
In addition to featuring presentations from a number of Notre Dame researchers, Vadim Backman, professor of biomedical engineering and medicine in hematology/oncology at Northwestern University, will provide the keynote address titled “Convergence of Nanoimaging and Biology: From Decoding Chromatin Packing to Cancer Diagnostics and Therapeutics.” During the address, Backman will discuss how the development of new technologies could help lead to the discovery of anti-cancer therapies and more.
In discussing the symposium, M. Sharon Stack, Kleiderer-Pezold Professor of Biochemistry and Ann F. Dunne & Elizabeth Riley Director of the HCRI, said, “Events like the Walther Cancer Foundation Symposium provide an opportunity for researchers to discuss their successes and challenges and establish new collaborations that may be pivotal to discovering solutions for combatting cancer. We are grateful to the Walther Cancer Foundation for providing us this opportunity.”
The two-day event will also include presentations by cancer researchers from Indiana University and Purdue University. To view the full symposium schedule, please visit https://harpercancer.nd.edu/news-events/events/2018/02/02/walther-cancer-foundation-symposium/.
Investigators in the HCRI are dedicated to conducting innovative and integrative research that confronts the complex challenges of cancer. From common malignancies to rare and recalcitrant cancers, researchers at Notre Dame and Indiana University School of Medicine-South Bend are united in multi-disciplinary teams with a common goal: to increase the survival of all patients diagnosed with cancer. To learn more, visit harpercancer.nd.edu.
Originally published by at research.nd.edu on February 01, 2018.